Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.340
+0.040 (1.74%)
At close: Dec 23, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 764.12 million as of December 24, 2025. Its market cap has decreased by -18.18% in one year.
Market Cap
764.12M
Enterprise Value
154.54M
Revenue
73.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.34
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 764.12M, a decrease of -86.17%. That is a compound annual growth rate of -28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 764.12M | -23.18% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.77B |
| Nordhealth AS | 2.94B |
| Photocure ASA | 1.82B |
| Thor Medical ASA | 1.60B |
| ArcticZymes Technologies ASA | 1.11B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 891.33M |
| Gentian Diagnostics ASA | 885.24M |